14 research outputs found

    Awareness and Attitude towards Plagiarism among Post Graduate Students and Research Scholars of Select Social Sciences Departments of Kurukshetra University and Panjab University, Chandigarh

    Get PDF
    This study explores the awareness and attitude towards plagiarism among postgraduate students and research scholars of Kurukshetra University, Kurukshetra (KU) and Panjab University, Chandigarh (PU). The findings of the questionnaire based study reveal that 53.64% of KU and 79.9% respondents of PU were acquainted with the term plagiarism. More than 41% respondents became aware of this term in their present university and more than half of the total respondents came to know about this concept during last one year. Only 23.97% had attended plagiarism awareness programmes. The understanding and attitude towards plagiarism needs greater attention. Maximum 88.35% respondents considered ‘Using someone’s ideas/words without acknowledging his/her’ as plagiarism while 48.63% did not consider ‘Helping your friend/classmate write a paper that must be submitted by him/her as an assignment’ as plagiarism. The main reason of plagiarism was lack of proper understanding of the concept and therefore it is suggested that awareness programmes on plagiarism and training programmes on methods of citation should be conducted

    Emerging and re-emerging viral infections in India

    Get PDF
    The number of outbreaks have  progressively increased since many years in India. In this era of globalization and rapid international travel, any infectious disease in one country can become a potential threat to the entire globe. Outbreaks of Nipah, Zika, Crimean- Congo Haemorrhagic Fever and Kyasanur Forest Disease and have been reported since a decade and now we are facing COVID 19 pandemic. One of the challenges in the prevention of these outbreaks is that as the cases decrease, the felt need declines, the public demand decreases and the mitigation responses get overshadowed by the need of emergency responses elsewhere. The One Health approach is a movement to promote alliance between medicine field, veterinary medicine and environmental sciences to upgrade the health of humans, animals, and ecosystem. The data in this article is compiled from different websites and publications of World Health Organization (WHO), Centre for Disease Control and Prevention (CDC), Integrated Disease Surveillance Programme (IDSP), grey literature and media. There is an urgent need for better surveillance and disease burden assessments in the country and to gain detailed insights into vector biology, factors of environment influencing the diseases, mapping of endemic areas, strengthen intersectoral coordination, infection control practices, and ensure use of Personal Protective Equipment’s (PPE) and availability of drugs and vaccines to handle the outbreaks in a better way

    Research Productivity on Human Migration in the Himalayan Region during 1947-2019: a Bibliometric Study

    Get PDF
    Purpose: The purpose of the present study is to find research productivity on \u27human migration in Himalayan region\u27 from 1947 to 2019. Methodology: The data of the present study have been collected from the International bibliographic database \u27Scopus\u27. Total 582 documents were extracted from 282 sources for the Himalayan region (China, India, Pakistan, Nepal, Tajikistan, Myanmar, Bhutan, and Afghanistan) under the category of \u27Social Science\u27 for the period 1947-2019. Data analysis was conducted by using bibliometric software, namely RStudio\u27s Biblioshiny and Microsoft office, version 2013. Results: The results reveal that the year 2019 was the most productive year for human migration publications (86 papers). Out of 582 documents, 506 publications are in research paper form. American Journal of Physical Anthropology (22 papers) is the most favored journal by the researchers. Li X is the most prolific author, publishing 23 articles on the topic. China (153) is a highly collaborative and most cited (2505) countr

    COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis

    No full text
    Objectives: The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to assess short-term COVID-19 vaccination-related adverse events (AEs) in rheumatoid arthritis (RA) patients. Methods: An online self-reported questionnaire (March-December 2021) was used to capture data related to COVID-19 vaccination-related AEs in RA, other autoimmune rheumatic diseases (AIRDs) (excluding RA and inflammatory myositis), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HCs). Descriptive and multivariable regression analyses were performed. Results: Of the 9462 complete respondents, 14.2% (n = 1347) had been diagnosed with RA who had a mean (standard deviation) age of 50.7 (13.7) years, and 74.2% were women, and 49.3% were Caucasian. In total, 76.9% and 4.2% of patients with RA reported minor and major AEs, respectively. Patients with active and inactive RA had similar AE and hospitalization frequencies. Overall, AEs were reported more frequently by BNT162b2 and mRNA-1273 recipients and less frequently by BBV152 recipients compared with the rest. Major AE and hospitalization frequencies were similar across recipients of different vaccines. Patients receiving methotrexate and hydroxychloroquine reported fewer minor AEs than those patients not on them. Compared with HCs and patients with other AIRDs, patients with RA reported similar total AEs, overall minor AEs, and hospitalizations. Compared with nrAIDs, patients with RA reported lower frequencies of overall AEs, minor AEs (both OR = 0.7; 95%CI = 0.5-0.9), and injection site pain (OR = 0.6; 95%CI = 0.5-0.8) with similar major AE and hospitalization frequencies. Conclusion: Despite the differences in AE frequency across different COVID-19 vaccines, all were well tolerated in patients with RA and were comparable to HCs providing reassurance to the safety of COVID-19 vaccination in them

    Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study

    No full text
    corecore